Prediction of Thromboembolic Events in Anticoagulated Patients with Atrial Fibrillation: Comparison of CHA2DS2-VASc and GARFIELD-AF Stroke Risk Scores

18 March 2019 (15:35 - 16:25)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Associate Professor Marco Proietti

University of Milan, Milan (Italy)

5 More presentations in this session

Presentation thumbnail

Diabetes mellitus, time in the therapeutic range and adverse outcomes in patients with atrial fibrillation: insights from the AFFIRM study

Doctor M. Proietti (Milan, IT)

Abstract Slides

Presentation thumbnail

Different obesity paradox of ischemic stroke without and with atrial fibrillation

Assistant Professor Y. Baek (Incheon, KR)

Presentation thumbnail

Usefulness of CHADS2-VASc score in predicting stroke in patients with atrial fibrillation and heart failure with preserved ejection fraction

Doctor A. Berkovitch (Ramat Gan, IL)

Abstract Slides

Presentation thumbnail

Thromboembolic events associated with cardioversion of atrial fibrillation in patients randomized to antiplatelet treatment in the ACTIVE trials

Doctor W. McIntyre (Hamilton, CA)

Abstract Slides

Presentation thumbnail

Thromboembolism after electrical isolation of the left atrial appendage: a new indication for interventional closure

Doctor S. Bordignon (Frankfurt, DE)

Abstract Slides

Access the full session

Session thumbnail

Moderated ePosters 11: AF: stroke and anticoagulation

The Event

EHRA 2019

18 March 2019 15:35 CET

You may be interested in

Congress Session

Stroke prevention in clinical and subclinical atrial fibrillation

Congress Presentation

State-of-the-art lecture on stroke and bleeding risk in atrial fibrillation: walking the tight rope

Congress Session

EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources